Abdulazeez Salawu

8PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Impact of Frontline Systemic Treatment Choice on Clinical Outcome in Advanced Leiomyosarcoma: A CanSaRCC Study.

|Jun 04, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft-Tissue Sarcoma.

|May 26, 2026
A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

|Sep 18, 2024
Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcoma.

Dina Braik, Christopher Lemieux, Brooke E Wilson

|Sep 09, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Fiona Collinson, Kara-Louise Royle, Jayne Swain

|Jun 18, 2024
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Abdulazeez Salawu, Eoghan R Malone, Esmail Al-Ezzi

Pageof 2

Frequent Collaborators

2 joint publications

Albiruni R Abdul Razak

1 joint publications

Lynda Wyld

1 joint publications

Ben X Wang

1 joint publications

Ming Han